A one-year-old girl suffered severe burns during a family BBQ, the contents of a deep fat fryer were spilt over the child covering her with boiling hot fat.
In the burns unit, it soon became clear that the girl had allergic reactions to the existing treatment products.
Philippe Sollie, a pharmacist at the time, contacted the head of the burns department and together they started developing a product to help.
Philippe Sollie founded Flen Health, at that time Flen Pharma. The same year Flamigel® was launched in Belgium, The Netherlands and Greece. Also, outside Europe, the product became a core element in the wound and skin therapy market. Saudi Arabia and China were the first export countries.
The company started to extend the product portfolio with Flamirins®, a wound cleanser.
Flen Health introduced extracalm® to the market as well as its first headquarters in Belgium.
A second headquarters in Luxembourg was opened. Flen Health has continued to grow and develop internationally.
Flen Health took distribution of its products back in own hands and opened affiliates in The Netherlands, Germany and the UK.
The company held a workforce of 80 staff and brought 145,000kg of wound and skin healing ointment into the market.
Foundation of US affiliate. More than 100 motivated employees work in six affiliates across the globe. The company’s product portfolio is distributed in over 25 countries worldwide.
Celebration of 20 years Flen Health! 20 years of successfully identifying unmet needs by utilising our expertise and passion to develop safe, effective and easy-to-use skin and wound healing products.